NCT06308549Completed
MyDiaMate For Remission Of Diabetes Distress In Type 1 Diabetes (MyREMEDY)
MyDiaMate For Remission Of Diabetes Distress In Type 1 Diabetes (MyREMEDY): A Multi-National Randomised-Controlled Trial
Source: ClinicalTrials.gov · Last updated 2 Jul 2026
Brief summary (registry, in English)
In the MyREMEDY study the investigators research whether the MyDiaMate self-help application is effective in strengthening the mental health of adults with type 1 diabetes in comparison with care as usual. The MyREMEDY study takes place in four countries: The Netherlands, United Kingdom, Spain, and Germany.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 625 (actual)
- First submitted
- 15 Feb 2024
- Start date
- 3 Apr 2024
- Primary completion date
- 30 Jan 2026
- Lead sponsor
- Maartje de Wit
- Diseases
- Type 1 diabetes
- NCT number
- NCT06308549
What you commit to
- Study type: Interventional
- Participants enrolled: 625
- From 3 Apr 2024 to the primary completion date, 30 Jan 2026
- 4 sites in 4 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Having started a treatment with psychotropic medication in the past 3 months
- Prior use of MyDiaMate (only applicable to participants in the Netherlands)
Other illness
- Having been diagnosed with a psychiatric disorder in the past 6 months for which the person is under psychological/psychiatric treatment
Other
- Suicidality
- Illiteracy
- Experience of cognitive problems that hamper using MyDiaMate or vision/auditory problems that are hindering in daily life
Who the study is looking for
- At least 18 years old at signing the informed consent form
- Type 1 diabetes diagnosis at least 6 months ago
- Having access to the internet and a smartphone/tablet/laptop'/computer for the entire time of study participation
- Experiencing diabetes distress (checked during a phone call between research assistant and participant. The condition is met if the participant has an average score of ≥2 on the 2-item Diabetes Distress Scale (DDS-2), representing clinically meaningful diabetes distress)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Forschungsinstitut Diabetes-Akademie Bad Mergentheim Coordinator of this site? Confirm its status | Bad Mergentheim | Germany | Unknown status |
| Universidad de Málaga Coordinator of this site? Confirm its status | Málaga | Spain | Unknown status |
| King's College London Coordinator of this site? Confirm its status | London | United Kingdom | Unknown status |
| Amsterdam UMC Coordinator of this site? Confirm its status | Amsterdam | Netherlands | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.